We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · July 06, 2020

Safety and Efficacy of Protamine for Preventing Bleeding Complications in TAVR

JACC: Cardiovascular interventions

 

Additional Info

JACC: Cardiovascular interventions
Safety and Efficacy of Protamine Administration for Prevention of Bleeding Complications in Patients Undergoing TAVR
JACC Cardiovasc Interv 2020 Jun 22;13(12)1471-1480, B Al-Kassou, J Kandt, L Lohde, J Shamekhi, A Sedaghat, N Tabata, M Weber, A Sugiura, R Fimmers, N Werner, E Grube, H Treede, G Nickenig, JM Sinning

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading